Despite the positive correlation between high IDO1 expression and advanced cancer stage or poor patient prognosis[25–29, 31–36, 38], the negative correlation is found in patients with RCC[103] and contradictory correlations are documented in patients with HCC[104, 105]. Here, IDO1 is linked to cancer.